SAMP3_HALVD
ID SAMP3_HALVD Reviewed; 92 AA.
AC D4GVB0;
DT 14-MAY-2014, integrated into UniProtKB/Swiss-Prot.
DT 14-MAY-2014, sequence version 2.
DT 25-MAY-2022, entry version 50.
DE RecName: Full=Small archaeal modifier protein 3;
DE Short=SAMP3;
DE AltName: Full=Ubiquitin-like small archaeal modifier protein 3;
GN Name=samp3; OrderedLocusNames=HVO_2177;
OS Haloferax volcanii (strain ATCC 29605 / DSM 3757 / JCM 8879 / NBRC 14742 /
OS NCIMB 2012 / VKM B-1768 / DS2) (Halobacterium volcanii).
OC Archaea; Euryarchaeota; Stenosarchaea group; Halobacteria; Haloferacales;
OC Haloferacaceae; Haloferax.
OX NCBI_TaxID=309800;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=ATCC 29605 / DSM 3757 / JCM 8879 / NBRC 14742 / NCIMB 2012 / VKM
RC B-1768 / DS2;
RX PubMed=20333302; DOI=10.1371/journal.pone.0009605;
RA Hartman A.L., Norais C., Badger J.H., Delmas S., Haldenby S., Madupu R.,
RA Robinson J., Khouri H., Ren Q., Lowe T.M., Maupin-Furlow J.,
RA Pohlschroder M., Daniels C., Pfeiffer F., Allers T., Eisen J.A.;
RT "The complete genome sequence of Haloferax volcanii DS2, a model
RT archaeon.";
RL PLoS ONE 5:E9605-E9605(2010).
RN [2]
RP FUNCTION, AMPYLATION AT GLY-92, AND DISRUPTION PHENOTYPE.
RC STRAIN=DS2 / DS70;
RX PubMed=21368171; DOI=10.1073/pnas.1018151108;
RA Miranda H.V., Nembhard N., Su D., Hepowit N., Krause D.J., Pritz J.R.,
RA Phillips C., Soll D., Maupin-Furlow J.A.;
RT "E1- and ubiquitin-like proteins provide a direct link between protein
RT conjugation and sulfur transfer in archaea.";
RL Proc. Natl. Acad. Sci. U.S.A. 108:4417-4422(2011).
RN [3]
RP FUNCTION AS A PROTEIN MODIFIER, PROTEIN TARGETS, CROSS-LINK, INDUCTION,
RP MUTAGENESIS OF 91-GLY-GLY-92, AND IDENTIFICATION OF START SITE.
RC STRAIN=DS2 / DS70;
RX PubMed=24097257; DOI=10.1074/mcp.m113.029652;
RA Miranda H.V., Antelmann H., Hepowit N., Chavarria N.E., Krause D.J.,
RA Pritz J.R., Basell K., Becher D., Humbard M.A., Brocchieri L.,
RA Maupin-Furlow J.A.;
RT "Archaeal ubiquitin-like SAMP3 is isopeptide-linked to proteins via a UbaA-
RT dependent mechanism.";
RL Mol. Cell. Proteomics 13:220-239(2014).
RN [4]
RP STRUCTURE BY NMR, AND SUBUNIT.
RC STRAIN=DS2;
RX PubMed=23821306; DOI=10.1002/pro.2305;
RA Li Y., Maciejewski M.W., Martin J., Jin K., Zhang Y., Maupin-Furlow J.A.,
RA Hao B.;
RT "Crystal structure of the ubiquitin-like small archaeal modifier protein 2
RT from Haloferax volcanii.";
RL Protein Sci. 22:1206-1217(2013).
CC -!- FUNCTION: Functions as a protein modifier covalently attached to lysine
CC residues of substrate proteins. The protein modification process is
CC termed sampylation and involves the formation of an isopeptide bond
CC between the SAMP3 C-terminal glycine carboxylate and the epsilon-amino
CC group of lysine residues on target proteins. Seems to be able to form
CC polymeric chains with itself at Lys-18, Lys-55 and Lys-62, similar to
CC ubiquitin and other ubiquitin-like proteins. SAMP3 appears not to serve
CC as a proteolytic signal in the cell to target proteins for degradation
CC by proteasomes. May regulate molybdenum cofactor (MoCo) biosynthesis by
CC inhibiting the activity of MPT synthase MoaE under aerobic conditions,
CC providing a hierarchy of oxygen use prior to that of alternative
CC electron acceptors such as DMSO. {ECO:0000269|PubMed:21368171,
CC ECO:0000269|PubMed:24097257}.
CC -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:23821306}.
CC -!- INDUCTION: Up-regulated by the addition of dimethyl sulfoxide to
CC aerobically growing cells. These conditions also increase the levels of
CC SAMP3 conjugates in cells. {ECO:0000269|PubMed:24097257}.
CC -!- PTM: The C-terminal glycine is likely acyl-adenylated (-COAMP) by UbaA.
CC -!- DISRUPTION PHENOTYPE: Cells lacking this gene grow similarly to wild-
CC type in the presence of either DMSO or oxygen as the terminal electron
CC acceptor; thus, SAMP3 is not needed for DMSO respiration, suggesting
CC that it is not required for molybdenum cofactor (MoCo) biosynthesis.
CC tRNA thiolation is not affected. {ECO:0000269|PubMed:21368171}.
CC -!- SEQUENCE CAUTION:
CC Sequence=ADE02783.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; CP001956; ADE02783.1; ALT_INIT; Genomic_DNA.
DR RefSeq; WP_004042069.1; NZ_AOHU01000041.1.
DR PDB; 2M19; NMR; -; A=1-92.
DR PDBsum; 2M19; -.
DR AlphaFoldDB; D4GVB0; -.
DR BMRB; D4GVB0; -.
DR SMR; D4GVB0; -.
DR STRING; 309800.C498_06178; -.
DR EnsemblBacteria; ADE02783; ADE02783; HVO_2177.
DR GeneID; 8923994; -.
DR KEGG; hvo:HVO_2177; -.
DR eggNOG; arCOG00536; Archaea.
DR HOGENOM; CLU_114601_1_2_2; -.
DR OrthoDB; 119587at2157; -.
DR Proteomes; UP000008243; Chromosome.
DR GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR Gene3D; 3.10.20.30; -; 1.
DR InterPro; IPR012675; Beta-grasp_dom_sf.
DR InterPro; IPR010038; MoaD_arc-typ.
DR InterPro; IPR016155; Mopterin_synth/thiamin_S_b.
DR InterPro; IPR003749; ThiS/MoaD-like.
DR Pfam; PF02597; ThiS; 1.
DR SUPFAM; SSF54285; SSF54285; 1.
DR TIGRFAMs; TIGR01687; moaD_arch; 1.
PE 1: Evidence at protein level;
KW 3D-structure; Isopeptide bond; Nucleotide-binding; Phosphoprotein;
KW Reference proteome; Ubl conjugation; Ubl conjugation pathway.
FT CHAIN 1..92
FT /note="Small archaeal modifier protein 3"
FT /id="PRO_0000428940"
FT MOD_RES 92
FT /note="Glycyl adenylate; alternate"
FT /evidence="ECO:0000269|PubMed:21368171"
FT CROSSLNK 18
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SAMP3)"
FT CROSSLNK 55
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SAMP3)"
FT CROSSLNK 62
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SAMP3)"
FT CROSSLNK 92
FT /note="Glycyl lysine isopeptide (Gly-Lys) (interchain with
FT K-? in acceptor proteins); alternate"
FT MUTAGEN 91..92
FT /note="Missing: Abolishes conjugation of SAMP3 to protein
FT targets."
FT /evidence="ECO:0000269|PubMed:24097257"
FT STRAND 1..7
FT /evidence="ECO:0007829|PDB:2M19"
FT HELIX 10..15
FT /evidence="ECO:0007829|PDB:2M19"
FT STRAND 18..25
FT /evidence="ECO:0007829|PDB:2M19"
FT HELIX 30..40
FT /evidence="ECO:0007829|PDB:2M19"
FT HELIX 42..44
FT /evidence="ECO:0007829|PDB:2M19"
FT TURN 45..48
FT /evidence="ECO:0007829|PDB:2M19"
FT STRAND 59..62
FT /evidence="ECO:0007829|PDB:2M19"
FT STRAND 72..75
FT /evidence="ECO:0007829|PDB:2M19"
FT STRAND 82..86
FT /evidence="ECO:0007829|PDB:2M19"
SQ SEQUENCE 92 AA; 10046 MW; 425F8EA3DE9904A3 CRC64;
MELELRFFAT FREVVGQKSI YWRVDDDATV GDVLRSLEAE YDGLAGRLIE DGEVKPHVNV
LKNGREVVHL DGMATALDDG DAVSVFPPVA GG